Skip to content
Menu
Menu
Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research
Back to Search Page
Why do patients with obesity discontinue glucagon-like peptide 1 analogues?
Categories:
Economic Costs
,
Medications
,
Weight Loss/Management
Type Article
Authors
Almohaileb FI, le Roux CW, Crotty M.
Year of publication
2025
Publication/Journal
Diabetes Obes Metab
Volume
27
Issue
9
Pages
5342-5345
Abstract
No abstract available